|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61K 47/12 | |||
| A61P 1/00 | |||
| A61P 17/00 | |||
| A61P 37/08 |
| (11) | Number of the document | 2344183 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09819568.8 |
| Date of filing the European patent application | 2009-10-09 | |
| (97) | Date of publication of the European application | 2011-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2015-02-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/005535 |
| Date | 2009-10-09 |
| (87) | Number | WO 2010/042203 |
| Date | 2010-04-15 |
| (30) | Number | Date | Country code |
| 104607 P | 2008-10-10 | US |
| (72) |
BERNER, Bret, US
|
| (73) |
Alvine Pharmaceuticals, Inc.,
75 Shoreway Road, Suite B, San Carlos, CA 94070,
US
|
| (54) | DOSAGE FORMS THAT FACILITATE RAPID ACTIVATION OF ZYMOGEN |
| DOSAGE FORMS THAT FACILITATE RAPID ACTIVATION OF ZYMOGEN |